Zdrowie i gospodarka · 23/10/2013
FDA Releases Guidance for Industry on Developing Antibacterial Drugs for ABSSSI Treatment
The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop new antibacterial drugs for treating acute bacterial skin and skin structure infections (ABSSSI).
Source: Federal Register — Food and Drug AdministrationOpen original release →